霉浆菌检测市场规模、份额及成长分析（按产品、技术、应用、最终用户和地区）－2025 年至 2032 年产业预测

2023 年全球霉浆菌检测市场规模为 8.324 亿美元，预计将从 2024 年的 8.9733 亿美元成长到 2032 年的 16.3644 亿美元，预测期内（2025-2032 年）的复合年增长率为 7.8%。

由于製药和生物技术领域的污染问题日益严重，霉浆菌检测市场预计将大幅成长。生物製药行业不断增长的研究倡议和对霉浆菌检测套组日益增长的需求是主要的成长动力。由于医疗保健基础设施的改善以及欧洲药品管理局（EMA）和美国食品药物管理局（FDA）等机构加强监管，要求对生技药品和疫苗进行严格测试，预计新兴市场将促进这一趋势。此外，Minerva Biolabs GmbH 的高灵敏度 VenorGeM Advance 侦测等技术创新正在提高侦测的准确性和效率。由于这种综合需求、监管支援和技术创新，霉浆菌检测市场预计将在未来几年大幅扩张。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术分析

霉浆菌检测市场规模（按产品）

• 市场概览
• 装置
• 套件和试剂
  • PCR检测
  • 核酸检测试剂套件
  • 污垢
  • 拆卸套件
  • 标准与管理
  • 其他的
• 服务

霉浆菌检测市场规模（按技术）

• 市场概览
• PCR
• ELISA
• 直接分析
• 间接分析
• 微生物培养技术
• 酵素法

霉浆菌检测市场规模（依应用）

• 市场概览
• 细胞株测试
• 病毒检测
• 电池报废检查
• 其他的

霉浆菌检测市场规模（依最终用户划分）

• 市场概览
• 学术研究所
• 细胞库
• 合约研究组织
• 製药和生物技术公司
• 其他的

霉浆菌检测市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Thermo Fisher Scientific Inc.（USA）
• Merck KGaA（Germany）
• Lonza Group Ltd.（Switzerland）
• Charles River Laboratories International Inc.（USA）
• Eurofins Scientific SE（Luxembourg）
• Roche Diagnostics（Switzerland）
• Agilent Technologies Inc.（USA）
• Bio-Rad Laboratories Inc.（USA）
• Sartorius AG（Germany）
• bioMerieux SA（France）
• Asahi Kasei Corporation（Japan）
• American Type Culture Collection（ATCC）（USA）
• Bionique Testing Laboratories Inc.（USA）
• InvivoGen（USA）
• PromoCell GmbH（Germany）
• Biological Industries Israel Beit Haemek Ltd.（Israel）
• Creative Bioarray（USA）
• Mycoplasma Experience（UK）
• Norgen Biotek Corp.（Canada）
• Biotools B & M Labs SA（Spain）

结论和建议

Global Mycoplasma Testing Market size was valued at USD 832.4 million in 2023 and is poised to grow from USD 897.33 million in 2024 to USD 1636.44 million by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).

The mycoplasma testing market is poised for significant growth, driven by increased contamination issues within the pharmaceutical and biotechnology sectors. Rising research initiatives and heightened demand for mycoplasma testing kits in biopharmaceutical industries are primary growth catalysts. Emerging markets are expected to contribute to this trend, bolstered by improved healthcare infrastructures and regulatory mandates from bodies like the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA), which enforce stringent testing for biologics and vaccines. Moreover, technological innovations, exemplified by Minerva Biolabs GmbH's highly sensitive VenorGeM Advance assay, are enhancing testing accuracy and efficiency. This synergistic growth of demand, regulatory support, and innovation positions the mycoplasma testing market for substantial expansion in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mycoplasma Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mycoplasma Testing Market Segments Analysis

Global Mycoplasma Testing Market is segmented by Product, Technology, Application, End-User and region. Based on Product, the market is segmented into Instruments, Kits & Reagents and Services. Based on Technology, the market is segmented into PCR, ELISA, Direct Assay, Indirect Assay, Microbial Culture Techniques and Enzymatic Methods. Based on Application, the market is segmented into Cell Line Testing, Virus Testing, End of Production Cells Testing and Others. Based on End-User, the market is segmented into Academic Research Institutes, Cell Banks, Contract Research Organizations, Pharmaceutical & Biotechnology Companies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mycoplasma Testing Market

The Global Mycoplasma Testing market is experiencing a significant surge in demand, primarily fueled by the growing research and development efforts in the biotechnology and pharmaceutical sectors, particularly concerning cell-based therapies and vaccines. As the reliance on cell lines for production intensifies, the necessity for contamination-free cell line streams has become critical. Moreover, as companies place a greater emphasis on quality assurance in their research processes, the demand for mycoplasma testing continues to escalate, alongside the need for more stringent and effective testing protocols. This trend highlights the crucial role of mycoplasma testing in ensuring product safety and efficacy in the industry.

Restraints in the Global Mycoplasma Testing Market

The Global Mycoplasma Testing market faces significant challenges due to a shortage of skilled personnel proficient in contemporary testing methodologies. Effective mycoplasma testing relies heavily on expert knowledge and proper implementation of testing procedures, and the scarcity of adequately trained professionals could impede progress in this field. This issue is particularly pronounced in developing countries, where resources for training and education are often limited, further obstructing the widespread adoption of mycoplasma testing solutions. The lack of expertise not only affects the implementation of existing techniques but also hinders innovations and improvements that could benefit the industry as a whole.

Market Trends of the Global Mycoplasma Testing Market

The Global Mycoplasma Testing market is experiencing a significant trend towards automation within laboratory operations, particularly in the biopharmaceutical sector. Automated systems streamline mycoplasma testing processes, drastically reducing testing times and enhancing productivity while minimizing human error. As biopharmaceutical companies increasingly emphasize process efficiency and consistency in quality, the demand for advanced mycoplasma testing technologies is projected to rise. This shift towards automation aligns with broader industry trends aimed at optimizing research and manufacturing practices, ultimately driving growth and innovation in the mycoplasma testing market as companies seek to ensure product safety and efficacy.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis

Global Mycoplasma Testing Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Kits & Reagents
  • PCR Assays
  • Nucleic Acid Detection Kits
  • Stains
  • Elimination Kits
  • Standards & Controls
  • Others
• Services

Global Mycoplasma Testing Market Size by Technology & CAGR (2025-2032)

• Market Overview
• PCR
• ELISA
• Direct Assay
• Indirect Assay
• Microbial Culture Techniques
• Enzymatic Methods

Global Mycoplasma Testing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Cell Line Testing
• Virus Testing
• End of Production Cells Testing
• Others

Global Mycoplasma Testing Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Academic Research Institutes
• Cell Banks
• Contract Research Organizations
• Pharmaceutical & Biotechnology Companies
• Others

Global Mycoplasma Testing Market Size & CAGR (2025-2032)

• North America (Product, Technology, Application, End-User)
  • US
  • Canada
• Europe (Product, Technology, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• American Type Culture Collection (ATCC) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionique Testing Laboratories Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InvivoGen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biological Industries Israel Beit Haemek Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Bioarray (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mycoplasma Experience (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norgen Biotek Corp. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotools B & M Labs S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations